Psychopathology in paediatric systemic lupus erythematosus

Area of Science:

• Pediatric Rheumatology
• Child and Adolescent Psychiatry
• Clinical Immunology

Background:

• Systemic lupus erythematosus (SLE) in children under 16 often presents with a poorer prognosis compared to adults.
• Anxiety and depressive symptoms are frequently observed in pediatric SLE patients, yet their specific associations with disease characteristics remain understudied.

Purpose of the Study:

• To assess the prevalence of anxiety and depressive symptoms in pediatric SLE patients.
• To investigate the relationship between these psychiatric symptoms, disease activity, and immunosuppressive treatments.

Main Methods:

• A cross-sectional study involving 40 pediatric patients (9-17 years) with SLE.
• Data collection included patient interviews, recording of immunosuppressive treatments, time to diagnosis, disease activity, and validated questionnaires for psychiatric symptoms and quality of life.

Main Results:

• 60% of patients exhibited anxiety symptoms; depression was less common.
• No significant correlation was found between SLE disease activity and psychiatric manifestations.
• Prednisone use was associated with higher anxiety symptom scores (p=0.002).

Conclusions:

• Anxiety is more prevalent than depression in pediatric SLE.
• Corticosteroid use (specifically prednisone) and anxiety are identified as vulnerability factors for psychopathology in this population.
• SLE significantly impacts patients' quality of life, independent of disease activity.